Dr. Wierda Discusses the CLL11 Trial

Описание к видео Dr. Wierda Discusses the CLL11 Trial

William G. Wierda, MD, PhD, professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the CLL11 trial, a three-arm trial comparing chlorambucil versus chlorambucil plus rituximab versus chlorambucil plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia (CLL).

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Комментарии

Информация по комментариям в разработке

Похожие видео